Page 572 - Multidisipliner Covid 19

BÖLÜM 30

30. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical
characteristics of 140 patients infected with SARS-CoV-2 in Wuhan,
China. Allergy 2020 Feb 19. [Epub ahead of print], doi: 10.1111/all.
14238.
31. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneu-
monia outbreak associated with a new coronavirus of probable bat
origin. Nature 2020;579:270–3.
32. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular
system. Nat Rev Cardiol 2020 Mar 5. [Epub ahead of print], doi: 10.
1038/s41569-020-0360-5.
33. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and
diabetes mellitus at increased risk for COVID-19 infection? Lancet
Respir Med 2020 Mar 11. [Epub ahead of print], doi: 10.1016/S2213-
2600(20)30116-8.
34. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Char-
acteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020
Feb 28. [Epub ahead of print], doi: 10.1056/NEJMoa2002032.
35. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet 2020
Mar 13. [Epub ahead of print], doi: 10.1016/S0140-6736(20)30627-9.
36. 99% of Those Who Died From Virus Had Other Illness, Italy Says-
Bloomberg Available at: https://www.bloomberg.com/news/articles/
2020-03-18/99-of-those-who-died-from-virus-had-other-illness-italy-
says. 2020.Accessed Mar 23
37. Palmieri L, Andrianou X, Bella A, Bellino S, Boros S, Canevelli M, et
al. Characteristics of COVID-19 patients dying in Italy Reportbased
on available data on March 20th, 2020. COVID-19 Surveillance Group.
2020.Available at:https://www. epicentro.iss.it/ coronavirus/
bollettino/Report-COVID-2019,20.marzo.eng.pdf. Accessed Mar 23
38. Leung C. Clinical features of deaths in the novel coronavirus epidemic
in China. Rev Med Virol 2020 Mar 16. [Epub ahead of print],doi: 10.
1002/rmv.2103.
39. Tocci G, Nati G, Cricelli C, Parretti D, Lapi F, Ferrucci A, et al. Preva-
lence and control of hypertension in the general practice inItaly:
updated analysis of a large database. J Hum Hypertens 2017;31:258–62.
40. Alhawassi TM, Krass I, Pont LG. Prevalence, prescribing and barriers
o effective management of hypertension in older populations: a nar-
rative review. J Pharm Policy Pract 2015;8:24.tkd

571